Unraveling Mysteries of the Brain Series
SAN FRANCISCO. (Ivanhoe Newswire) – DIPG is the second most common brain tumor in kids. The diagnosis is tough to deliver. It is almost always the same—little boys and girls are given less than two years to live. In fact, the median survival rate is only nine months and so far, there are no good treatment options. But doctors hope one family’s sacrifice will change all of that!
PITTSBURGH. (Ivanhoe Newswire) -- HHT is a genetic disorder of the blood vessels. In severe cases it can lead to sudden bleeding or stroke. Researchers say HHT affects more than one in 5,000 people, but 90 percent of all people with HHT don’t know they have it. Now, new research may unlock the mystery behind the disease and give patients the best chance for treatment and a cure.
NEW YORK. (Ivanhoe Newswire) -- Diffuse intrinsic pontine glioma or DIPG, is an invasive pediatric brain cancer…a tumor in the brain stem that is impossible to safely remove. Radiation and traditional chemotherapy may buy a patient some time, but ultimately, can’t save a child’s life. Luckily, researchers are testing a new way to deliver cancer-fighting drugs that may someday soon lead to a cure.
This search brought to you by ClinicalTrials.gov. Search other clinical trial listings on the Internet at CenterWatch.
Powered by Local.com